Related references
Note: Only part of the references are listed.CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly
F. Miyajima et al.
GENES BRAIN AND BEHAVIOR (2008)
CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
G. Li et al.
NEUROLOGY (2007)
BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls
Christoph Laske et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Estrogen-BDNF interactions: Implications for neurodegenerative diseases
Farida Sohrabji et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2006)
Using verbal fluency to detect very mild dementia of the Alzheimer type
Rowena G. Gomez et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2006)
Stage-dependent BDNF serum concentrations in Alzheimer's disease
C. Laske et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
BDNF val66 met allele is associated with reduced hippocampal volume in healthy subjects
JA Bueller et al.
BIOLOGICAL PSYCHIATRY (2006)
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
I Blasko et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
MF Egan et al.
CELL (2003)
Share Paper
